The Oxen Group is liking a bearish market or at least a somewhat sideways market. The market has jumped up for three straight days, and a technical pullback with investors taking profits may be in order. One area that appears fundamentally bearish is the housing sector. Ultrashort Proshares Real Estate (SRS), which is a housing/commercial real estate ETF, looks to be bearish on a general market trend as well as news that foreclosures are continuing to rise to now 15% for the year and 33% in June.
The trend is not stabilizing, which while not directly affecting commercial real estate means that commercial real estate is in a tough spot, as well. Futures are currently registering in the red, and we did not have any large market moving earnings or news come out in after hours. Further, news that CIT Group has failed to get lending and will be filing bankruptcy shows that the recession may still be taking more victims. Many earnings are coming out in the morning, but not a marquis name that could really drive the market higher except perhaps JPMorganChase. Economic data being released could further influence a pullback if jobless claims come in under expectations. Even if jobless claims are good and JPMorgan is solid, investors will be looking to sell these stocks into this upward trend. SRS, however, is in the exact opposite boat. The ETF is extremely undervalued, just passed under a lower bollinger band, and is way oversold. Therefore, it is setting up for a perfect buying opportunity.
Entry: Recommend buying in 15-30 minutes into session. Exit: We recommend exiting after a 2-5% increase. Stop Loss: We recommend a 3% stop loss on all buy in prices Upper Resistance: 21.00
The Oxen Group, for Wednesday, is looking at a continued bearish market for a third straight day. With today’s bullish economic data, investors still sold off stocks, pointing to a bear market that should continue as a bland day continues tomorrow. Most analysts think that Obama’s financial regulation plans will not do much for the market. Futures are up, in after hours, but with this data, if a rally cannot be held, then there is no reason to expect a positive day at this time. The CPI will determine the day.
One industry that really looks bearish tomorrow is housing. The housing industry got a shot with, on the surface, bullish news. Instead, the housing market ended up with minimal gains or in the red. Light volume shows that investors are not excited about the market.
Tomorrow should continue a downward trend for housing sparked by a downgrade of Beazer Homes to ultra-junk status by the S&P. That sent the stock down 10% in after hours. This is really a market that needs some very bullish jolt to get it going, and it until that happens this market is fundamentally bearish. With that said, Ultrashort Proshares Real Estate looks to be a strong play as an inverse to the housing industry, which should fall after its run up today. Technically, the ETF has been moving and is trending upwards with more buyers getting involved. Buyers are still on the sidelines to short housing. Buy in early and watch the run!
Entry: Recommend buying within first 5 – 25 minutes. Exit: We recommend exiting after a 2-4% increase. Upper Resistance: 22.50
This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible. Feel free to contact me directly at firstname.lastname@example.org with any questions.
Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts. After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.) Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.
Here come the revisionists with new malarkey about the 2008 financial crisis. No less august a forum than the New York Times today carries a front page piece by journeyman financial reporter James Stewart suggesting that Lehman Brothers was solvent; could and should have been bailed out; and that the entire trauma of the financial crisis and Great Recession might have been avoided or substantially mitigated:
What happened that September was the culmination o...
The S&P 500 closed September with a monthly loss of 1.55%. All three S&P 500 MAs and three of the five the Ivy Portfolio ETF MAs are signaling "Invested".
The Ivy Portfolio
The table below shows the current 10-month simple moving average (SMA) signal for each of the five ETFs featured in The Ivy Portfolio. I've also included a table of 12-month SMAs for the same ETFs for this popular alternative strategy.
For a facinating analysis of the Ivy Portfolio strategy, see this article by Adam Butler, Mike Philbrick and Rodrigo Gordillo:
The CBOE Vix Index topped 17.0 and the highest level since early-August on Monday morning amid declines in U.S. equities to start the trading week. The volatility index is off its earlier highs to trade 5.0% higher on the session at 15.65 as of 11:30 am ET. Options volume on the VIX is hovering near 360,000 contracts, or just more than 50% of the average daily reading of around 660,000 contracts. Calls are far more active than put options, as evidenced by the call/put ratio up above 4.2 in morning trading, perhaps as some traders position for volatility to stick around.
Large call spreads traded on the VIX today caught our attention as one big optio...
Yes, the market showed significant weakness last week for the first time in quite a while. In fact, the Dow Jones Industrial Average moved triple digits each day. But it was all quite predictable, as I suggested in last week's article, and certainly nothing to worry about. Now the market appears to be poised for a modest technical rebound, and longer term, U.S. equities should be in good shape for a year-end rally. However, I still believe more downside is in order before any new highs are challenged. Moreover, market breadth is important for a sustained bull run, so the challenge for investors will be to put together broader bullish conviction, including the small caps.
In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, re...
Reminder: OpTrader is available to chat with Members, comments are found below each post.
This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).
We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options.
Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.
To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here
Ebola is spreading too quickly for Ebola-vaccine makers to conduct typical studies of safety and efficacy on experimental vaccines. Instead, vaccines will be tested for basic safety, but then deployed with protocols devised now in order to test for efficacy essentially on the field. Testing has to be expedited because the situation in West Africa gets worse every day while there are no approved vaccines or other treatments.
The chart below is from a paper in the New England Journal of Medicine showing estimates of the virus's trajectory projecting out to November 1, 2014. If current trends continue...
Despite the various opinions on Bitcoin, there is no question as to its ultimate value: its ability to bypass government restrictions, including economic embargoes and capital controls, to transmit quasi-anonymous money to anyone anywhere.
Opinions differ as to what constitutes "money."
The English word "money" derives from the Latin word "moneta," which means to "mint." Historically, "money" was minted in the form of precious metals, most notably gold and silver. Minted metal was considered "money" because it possessed luster, was scarce, and had perceive...
Reminder: Pharmboy is available to chat with Members, comments are found below each post.
Well PSW Subscribers....I am still here, barely. From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.
First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices. Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment. Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer. For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...
Note: The material presented in this commentary is provided for
informational purposes only and is based upon information that is
considered to be reliable. However, neither MaddJack Enterprises, LLC
d/b/a PhilStockWorld (PSW) nor its affiliates
warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.
This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.